Navigation Links
New Treatment for Alzheimer's Disease

An early study of the drug rolipram in mice shows promise for possible use in treating Alzheimer's disease in people // say researchers according to a new study.

Alzheimer's disease is the most common form of dementia in the elderly with typical symptoms being memory loss, speech deterioration, and behavioral changes. The main factor in the cause of AD is the accumulation of beta-amyloid, which is toxic to the brain.

Researchers say they have found that treatment of a mouse form of AD with rolipram improves memory in long-term potential and contextual learning -- two measurements of brain function. Rolipram works by modifying gene expression, making brain synapses more resistant to the damage caused by accumulating beta amyloid.

Results have shown that rolipram's protective benefit lasted for two months after the drug course was stopped. The benefits of the treatment also were not limited to the early stages of AD, with behavioral changes occurring in older mice as well as younger mice.

In conclusion researchers say their study suggests that drugs, such as rolipram, that inhibit phosphodiesterase do have the potential to prevent the memory loss characteristic of Alzheimer's disease.
'"/>




Page: 1

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Treatment for Alzheimer Disease

(Date:4/25/2015)... MN (PRWEB) April 25, 2015 On ... recipient of RFID Journal’s annual Best Implementation Award. ... has demonstrated the best use of RFID technology to ... winner is the company that best demonstrates how RFID ... was presented at RFID Journal Live! 2015 in San ...
(Date:4/24/2015)... York, NY (PRWEB) April 24, 2015 ... sober living residence in Westchester County. Just 35 miles ... help transition individuals back into everyday life while recovering ... Thursday, May 7, 2015, will allow therapists, doctors and ... areas and learn more about the opportunities offered by ...
(Date:4/24/2015)... Ryadon is a leading manufacturer of ... and services to complement any custom hardware requirements you ... will be offered on all heavy duty drawer slides ... 10% discount - Order 20+: Receive 20% discount , ... Products, Furniture ,Drawer Slides, ...
(Date:4/24/2015)... New York, New York (PRWEB) April 24, 2015 ... continue to move forward in the federal ... of South Carolina. According to court documents, the ... Status Report on April 16th detailing, among other ... The report notes that counsel for both plaintiffs ...
(Date:4/24/2015)... The first step to transforming one’s life ... meditation and yoga teacher Stine Koppernæs, meditation and changing ... that allow her to experience more peace and freedom ... teacher since 2006, and through the years she has ... , “I love sharing this way of finding true, ...
Breaking Medicine News(10 mins):Health News:Seeonic’s Industry Leading Technology Powers Interstate Batteries to Winning Award 2Health News:Constellations Recovery Opens The First Luxury Sober Living Residence in Westchester New York 2Health News:Constellations Recovery Opens The First Luxury Sober Living Residence in Westchester New York 3Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 2Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 3Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 2Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 3
... may be possible with many low energy treatments than ... ,The results of this study were published in ... eight participants over a three-month period during which they ... regeneration treatments are done to reduce wrinkles and for ...
... of 654 new cases of dengue fever were reported across ... average of 400 new //cases a day last week, Paraguay's ... Nicanor Duarte Frutos has not yet declared the epidemic to ... declaration. ,Dengue fever is a viral infection ...
... with a condition that is a strong genetic predictor ... genetic counseling or cancer screening. //According to a recent ... screening rates could be improved if physicians provided stronger ... screening to their patients. ,“We studied families with ...
... New Delhi: The eradication of neglected tropical diseases should ... the World Health Organization (WHO).// ,Many people ... leprosy, lymphatic filaria, leishmaniasis and yaws. Dengue is emerging ... ,"These diseases cause great suffering and ill-health and have ...
... - A new study by researchers from Queen's University ... eye movement tests in the diagnosis of fetal alcohol ... called FASD affects children when mothers have consumed alcohol ... tasks, could help effectively measure FASD in children, the ...
... approved meat and milk from cloned animals while it conducts ... its customers and consumers don't want milk from cloned animals. ... among dozens of other brands. ,"Numerous surveys ... products that contain milk from cloned cows and Dean Foods ...
Cached Medicine News:Health News:WHO Urges Higher Priority for Neglected Diseases 2Health News:Milk from Cloned Cows is Not Welcome at the Nation's Biggest Milk Company 2
(Date:4/24/2015)... EAST HANOVER, N.J. , April 24, 2015  Novartis ... diversity for the second year in a row on the ... the results of its 2015 Top 50 Companies for Diversity ... New York, NY . NPC also ranked second on ... on the Top 10 Companies for Employee Resource Groups list. ...
(Date:4/24/2015)... , April 24, 2015 /CNW/ - T-Bird Pharma ... focused on developing premium quality medical marijuana products and ... Marihuana for Medical Purposes Regulations ( Canada ... with certain of its shareholders, has closed the transaction ... ("Medna").  Medna has acquired (the "Escrow Transfer") a total ...
(Date:4/23/2015)... Ill. , April 24, 2015  AbbVie (NYSE: ... and Drug Administration (FDA) has accepted its New Drug ... all-oral, interferon-free, two direct-acting antiviral treatment of ombitasvir, paritaprevir, ... the treatment of adults with chronic genotype 4 (GT4) ... is the first all-oral, interferon-free therapy being evaluated by ...
Breaking Medicine Technology:Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 2Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 3Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 4T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences 2T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences 3U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 3U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 4U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 5U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 6U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 7
... LAKES, N.J., Jan. 11 BD (Becton, Dickinson and Company) (NYSE: ... live webcast of its first fiscal quarter 2010 earnings conference call ... will issue a press release detailing the quarter,s earnings earlier that ... slides, will be accessible through BD,s website at www.bd.com/investors ...
... , WASHINGTON, Jan. ... that Major League Baseball star Aaron Boone is featured in ... public affairs television program that tells the compelling and inspirational stories of ... television stations nationwide. It is sponsored by the Pharmaceutical Research and ...
Cached Medicine Technology:BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call 2Major League Baseball Star Aaron Boone on 'Sharing Miracles' 2Major League Baseball Star Aaron Boone on 'Sharing Miracles' 3
For the specific requirements of the posterior horn of the meniscus; the short, low profile jaw facilitates working in the tight confines of the posterior aspect of the knee....
... were developed in surgeon's desire to have ... an instrument with the strength to maneuver ... the bending or breaking. Arthrotek Hand Instruments ... to the surgeon's hand. This new generation ...
... Arthrotek® Precision Hand Instruments were developed in ... feel, while still having an instrument with ... without the fear of the bending or ... and manufactured to conform to the surgeon's ...
... were developed in surgeon's desire to have ... an instrument with the strength to maneuver ... the bending or breaking. Arthrotek Hand Instruments ... to the surgeon's hand. This new generation ...
Medicine Products: